Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

This study has been completed.
ICON Clinical Research
Information provided by:
Daiichi Sankyo Inc. Identifier:
First received: August 30, 2010
Last updated: July 11, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)